EIN 84-2367491

Medonect Therapeutics

IRS 501(c) type
501(c)(3)
Num. employees
Unknown
Year formed
2020
Most recent tax filings
2021-12-01
Description
Help in providing innovative safe and efficient healthcare solutions to cancer patients. Acceptance from FDA- Proof of Concept Acquired from FDA appointed laboratory. FDA continuous progress on the existing medical devices. Healthcare research and product development.
Total revenues
$99,194
2021
Total expenses
$100,194
2021
Total assets
$12,556
2021
Num. employees
n/a

Financials for Medonect Therapeutics

RevenuesFYE 12/2021
Total grants, contributions, etc.$99,194
Program services$0
Membership dues$0
Investment income and dividends$0
Net gain from sale of non-inventory assets$0
Net income from gaming activities and fundraising events, combined$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$99,194

Form 990s for Medonect Therapeutics

Fiscal year endingDate received by IRSFormPDF link
2020-122021-06-16990EZView PDF
2019-122021-06-17990EZView PDF
Data update history
February 28, 2022
Posted financials
Added Form 990EZ for fiscal year 2019
Nonprofit Types
Research centersHuman service organizationsCharities
Issues
Science and technologyHealthHuman servicesDiseases and disorders
Characteristics
Conducts researchPartially liquidatedTax deductible donationsNo full-time employees
General information
Address
3360 E Foothill St 446
Pasadena, CA 91107
Metro area
Los Angeles-Long Beach-Anaheim, CA
Phone
(213) 716-8557
IRS details
EIN
84-2367491
Fiscal year end
December
Taxreturn type
Form 990-EZ
Year formed
2020
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
P00: Human Services: General
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
Free account sign-up

Want updates when Medonect Therapeutics has new information, or want to find more organizations like Medonect Therapeutics?

Create free Cause IQ account